NCT04205071 2021-01-19Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast CancerOhio State University Comprehensive Cancer CenterPhase 1 Withdrawn